n-propionylprocainamide has been researched along with procainamide in 7 studies
| Studies (n-propionylprocainamide) | Trials (n-propionylprocainamide) | Recent Studies (post-2010) (n-propionylprocainamide) | Studies (procainamide) | Trials (procainamide) | Recent Studies (post-2010) (procainamide) |
|---|---|---|---|---|---|
| 12 | 0 | 9 | 3,612 | 174 | 122 |
| Protein | Taxonomy | n-propionylprocainamide (IC50) | procainamide (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Mus musculus (house mouse) | 3.9 | |
| Sterol O-acyltransferase 1 | Rattus norvegicus (Norway rat) | 1 | |
| Acetylcholinesterase | Homo sapiens (human) | 1 | |
| Acetylcholinesterase | Bos taurus (cattle) | 0.5 | |
| Sterol O-acyltransferase 1 | Homo sapiens (human) | 1 | |
| Solute carrier family 22 member 1 | Rattus norvegicus (Norway rat) | 7.35 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Kusowska, J | 2 |
| Kusowska, J; Polakowski, P | 1 |
| Bianchi, F; Cotugno, M; Forte, M; Marchitti, S; Rubattu, S; Stanzione, R | 1 |
| Chen, L; He, Y; Li, J; Lu, Y; Ma, S; Peng, H; Shen, B; Wu, L; Zhang, M; Zhang, Q; Zhang, R; Zhu, J | 1 |
| Fu, W; Jose, PA; Li, L; Liao, Q; Ren, H; Shi, Y; Shou, J; Wang, WE; Zeng, C | 1 |
| Book, M; Hahn, M; Luedi, MM; Rieder, HU; Stamer, UM; Stüber, F | 1 |
1 review(s) available for n-propionylprocainamide and procainamide
| Article | Year |
|---|---|
Epigenetic control of natriuretic peptides: implications for health and disease.
Topics: Animals; Atrial Natriuretic Factor; Disease; Epigenesis, Genetic; Gene Expression Regulation; Humans; MicroRNAs; Natriuretic Peptides; Procainamide; Protein Processing, Post-Translational; Receptors, Atrial Natriuretic Factor | 2020 |
6 other study(ies) available for n-propionylprocainamide and procainamide
| Article | Year |
|---|---|
[A new anti-arrhythmia drug. II. Comparative studies of the effects of a new acyl derivative of procainamide, procainamide and N-acetylprocainamide on blood pressure and the electrocardiogram in rabbits].
Topics: Acecainide; Animals; Arrhythmias, Cardiac; Blood Pressure; Drug Evaluation, Preclinical; Electrocardiography; Heart Rate; Procainamide; Rabbits | 1989 |
[New anti-arrhythmia drug. III. Comparative studies of the effects of N-propionylprocainamide, procainamide and N-acetylprocainamide on hemodynamics and cardiac blood flow].
Topics: Acecainide; Animals; Arrhythmias, Cardiac; Coronary Circulation; Drug Evaluation, Preclinical; Female; Hemodynamics; Male; Procainamide; Rabbits | 1989 |
[A new anti-arrhythmia drug. I. Study of the anti-arrhythmia effects of a new N-acyl derivative of procainamide in rabbits].
Topics: Animals; Arrhythmias, Cardiac; Drug Evaluation, Preclinical; Female; Male; Procainamide; Rabbits | 1988 |
NPPA Promoter Hypomethylation Predicts Central Obesity Development: A Prospective Longitudinal Study in Chinese Adults.
Topics: Atrial Natriuretic Factor; Body Mass Index; China; Cross-Sectional Studies; DNA Methylation; Female; Humans; Longitudinal Studies; Male; Middle Aged; Obesity; Obesity, Abdominal; Procainamide | 2022 |
Loss of NPPA-AS1 promotes heart regeneration by stabilizing SFPQ-NONO heteromer-induced DNA repair.
Topics: Animals; Atrial Natriuretic Factor; Cell Proliferation; DNA Repair; DNA-Binding Proteins; Mammals; Mice; Myocardial Infarction; Myocytes, Cardiac; Procainamide; Regeneration; RNA-Binding Proteins; RNA, Long Noncoding | 2022 |
ASA Status,
Topics: Atrial Natriuretic Factor; Coronary Artery Disease; Haplotypes; Humans; Natriuretic Peptide, Brain; Natriuretic Peptides; Nitrobenzoates; Peptide Fragments; Procainamide | 2022 |